1. Home
  2. SUGP vs INTS Comparison

SUGP vs INTS Comparison

Compare SUGP & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUGP
  • INTS
  • Stock Information
  • Founded
  • SUGP 1998
  • INTS 2012
  • Country
  • SUGP Hong Kong
  • INTS United States
  • Employees
  • SUGP N/A
  • INTS N/A
  • Industry
  • SUGP
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SUGP
  • INTS Health Care
  • Exchange
  • SUGP NYSE
  • INTS Nasdaq
  • Market Cap
  • SUGP 9.6M
  • INTS 9.4M
  • IPO Year
  • SUGP 2024
  • INTS 2023
  • Fundamental
  • Price
  • SUGP $0.50
  • INTS $0.32
  • Analyst Decision
  • SUGP
  • INTS Strong Buy
  • Analyst Count
  • SUGP 0
  • INTS 3
  • Target Price
  • SUGP N/A
  • INTS $8.50
  • AVG Volume (30 Days)
  • SUGP 146.6K
  • INTS 2.7M
  • Earning Date
  • SUGP 07-21-2025
  • INTS 08-07-2025
  • Dividend Yield
  • SUGP N/A
  • INTS N/A
  • EPS Growth
  • SUGP 1.19
  • INTS N/A
  • EPS
  • SUGP 0.11
  • INTS N/A
  • Revenue
  • SUGP $23,446,259.00
  • INTS N/A
  • Revenue This Year
  • SUGP N/A
  • INTS N/A
  • Revenue Next Year
  • SUGP N/A
  • INTS N/A
  • P/E Ratio
  • SUGP $4.70
  • INTS N/A
  • Revenue Growth
  • SUGP 11.29
  • INTS N/A
  • 52 Week Low
  • SUGP $0.35
  • INTS $0.26
  • 52 Week High
  • SUGP $3.25
  • INTS $5.10
  • Technical
  • Relative Strength Index (RSI)
  • SUGP 34.00
  • INTS 37.08
  • Support Level
  • SUGP $0.47
  • INTS $0.28
  • Resistance Level
  • SUGP $0.66
  • INTS $0.32
  • Average True Range (ATR)
  • SUGP 0.08
  • INTS 0.06
  • MACD
  • SUGP -0.02
  • INTS 0.01
  • Stochastic Oscillator
  • SUGP 30.36
  • INTS 7.43

About SUGP SU GROUP HLDGS LTD

SU Group Holdings Ltd and its subsidiaries is an integrated security-related services company. The company has two reportable segments: security-related engineering services, and security guarding and screening services and related vocational training services. The company generates the majority of its revenue from the security-related engineering services segment. Geographically operates in Hong Kong, and Other foreign countries, with maximum revenue from Kong Kong.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: